Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Androgel Lawsuit Discovery and Depositions Continuing in Preparation for Early Trials April 14, 2016 Austin Kirk Add Your Comments As a growing number of testosterone drug lawsuits continue to be filed by men throughout the U.S., discovery and depositions continue in a small group of Androgel cases that are being prepared for early trial dates in the federal multidistrict litigation (MDL). There are currently more than 5,000 Androgel lawsuits, Axiron lawsuits, Testim lawsuits, Androderm lawsuits and other claims brought over the side effects of testosterone replacement therapy, including claims for men who allegedly suffered a sudden heart attack, stroke, blood clot or death. Given the common questions of fact and law raised in the cases, complaints filed throughout the federal court system have been centralized for pretrial proceedings before U.S. District Judge Matthew Kennelly in the Northern District of Illinois. The process is designed to reduce duplicative discovery into common issues in the cases, avoid conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As part of the coordinated litigation, Judge Kennelly previously established a “bellwether” process, where a small group of cases filed against AbbVie, the makers of Androgel, are being prepared for early trial dates, since their testosterone gel is the most widely used of the “low T” drug on the market. A series of six cases are expected to go to trial between April and November 2017, which will help the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation. While the outcomes of these trials are not binding on other claims, they are being closely watched by those involved in the cases, as they may influence eventual negotiations to reach testosterone injury settlements. Androgel Bellwether Status Conference In advance of a conference before Judge Kennelly on April 13, the parties submitted a joint status report (PDF) that provides an update on the progress of discovery in the bellwether cases and outlines several areas of disagreement between the parties. AbbVie has indicated that some extensions in the discovery schedule will be required, claiming that more time is needed to produce certain documents and testimony due to the volume and timing of medical record collection, as well as the growing scope of sales representative discovery and difficulties coordinating deposition dates with many plaintiffs’ doctors. Attorneys serving on a Plaintiffs Steering Committee (PSC) are opposed to any further delays, arguing that it was inappropriate for the manufacturer to seek a delay in discovery as part of a status conference, indicating that it should be made with a proper motion before the Court. “With regard to AbbVie’s sudden request for an extension of the bellwether schedule, the PSC does not presently agree that another extension of the schedule is warranted because these dates and the amount of work required to complete both the core bellwether work-up and generic discovery were known to both parties and the Court at the time the schedule was recently amended/extended,” plaintiffs’ leadership counsel argued. “Notwithstanding, should AbbVie seek an extension, they should make a motion, rather than haphazardly submit contested and questionable facts and arguments into a joint report that they belatedly dropped on the PSC on the 11th hour without ample time for the PSC to truly respond.” According to minutes (PDF) entered on the docket following the status conference, any request by AbbVie to modify the current bellwether discovery, pretrial and trial schedule should be filed by April 15, with any response by plaintiffs due by April 19. The issue will likely be addressed at the next case management conference scheduled for May 19. During the conference, AbbVie also urged the Court to exclude from the bellwether process any lawsuit involving duel use of Androgel and another testosterone replacement product, indicating that such cases are too complex and unique to be representative or beneficial in gauging the strengths and weaknesses of arguments. However, plaintiffs argue that the mixed use cases that have been identified by AbbVie each involve, for the most part, uses of other testosterone drugs that were too remote from the date of the plaintiff’s injury to be a factor in the case. The current Androgel bellwether schedule calls for core discovery to be completed in 32 initial pool cases by May 23, 2016. A proposal for selection of the eligible trial cases is to be submitted by June 7, 2016, after which the court will select up to 12 claims for trial. Depositions of expert witnesses in those cases will be completed by December 2, 2016, following which any motions for Summary Judgement or challenges to the admissibility of expert testimony will be considered by the Court. Androgel trials are expected to begin on April 21, 2017; June 5, 2017; July 10, 2017; August 21, 2017; September 25, 2017 and November 6, 2017. Following these bellwether Androgel trial dates, a second series of trials are expected to be scheduled involving other “low T” drugs. Therefore, any further delays in the discovery and bellwether process will also have an impact on claims involving use of Axiron, Testim, Androderm or other testosterone drugs. Tags: AbbVie, AndroGel, Heart Attack, Stroke, Testosterone Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: yesterday) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: yesterday) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 2 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: yesterday) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: yesterday) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 2 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)